Pfizer

Economist and national executive council member of the Swadeshi Jagaran Manch (SJM), B.M. Kumaraswamy, said on Tuesday that vaccines are being manufactured by only two companies in India, and hence it would be difficult to vaccinate the…

Experts and multiple research reports reveal that most of the Covid patients fall under the mild to moderate category and recover easily on their own. Fifty percent of the mildly infected complain of loss of senses of smell and taste. And…

The Government on Tuesday informed that1895 new positive cases of novel Corona virus (COVID-19),633 from Jammu division and 1262 from Kashmir division, have been reported today, thus taking the total number of positive cases in Jammu and…

The second wave of Covid-19 has infiltrated more families than before. The health workers have been on their toes, working odd hours, ever since the first wave hit the nation; the pandemic has also had an emotional toll on them and…

 “It is our duty to serve people. And being able to do that especially during a pandemic is an once-in-a-lifetime experience. We are somehow blessed to be able to use our expertise amid this crisis,” says Dr Shweta posted in the Accidental…

The World Health Organisation (WHO) on Tuesday validated the Sinovac-CoronaVac Covid-19 vaccine for emergency use, giving countries, procuring agencies and communities the assurance that it meets international standards for safety, efficacy…

 Scientists created safe and effective vaccines against Covid-19 at an unprecedented speed. But, according to industry leaders, the next generation of Covid shots will be low in cost, easier to deliver and preserve and effective against…

District administration Poonch has provided all necessary medical facilities to 229 Panchayat level Corona Care Centres set up for the convenience of the covid positive patients in the rural areas.The distribution of the COVID Care material…

People with Covid-19 infection are likely to have strong immunity against coronavirus for at least a year after they were initially infected, according to a study.The study, led by scientists at the Rockefeller University, also showed that…

China pricing its Sinopharm vaccine differently for its different partners in South Asia has raised a ruckus. Allegations that Bangladesh is paying US $10 per dose while Sri Lanka is paying US $15 per dose for the Sinopharm vaccine has…